Skip to content

Anesthesia effect of different doses of remimazolam combined with remifentanil anesthesia application in laparoscopic ovarian cystectomy

Anesthesia effect of different doses of remimazolam combined with remifentanil anesthesia application in laparoscopic ovarian cystectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113214
Enrollment
Unknown
Registered
2025-11-26
Start date
2024-07-31
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cysts are common tumors of the female reproductive system, predominantly affecting women aged 20 to 50. Laparoscopic ovarian cystectomy, with its advantages of minimal trauma, reduced bleeding, and quicker postoperative recovery, has gradually replaced open surgery. However, the establishment of a carbon dioxide pneumoperitoneum during laparoscopic surgery can impact the patient's respirat

Interventions

Group C:Propofol 5.0mg/ (kg·h) + remifentanil 0.1µg/ (kg·h)
Group R1:Remimazolam 1.0mg/ (kg·h) + remifentanil 0.1µg/ (kg·h)
Group R2:Remimazolam 1.5mg/ (kg·h) + remifentanil 0.1µg/ (kg·h)
Group R3:Remimazolam 2.0mg/ (kg·h) + remifentanil 0.1µg/ (kg·h)

Sponsors

Ji 'an Central People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for the indications of laparoscopic ovarian cystectomy as stipulated in the "Modern Hospital Diagnosis and Treatment Routine (Surgery and Obstetrics and Gynecology Volume)" and be confirmed by imaging examinations; ASA grade I or II, aged 20 to 45 years old, body mass index (BMI) 18 to 28 kg/m^2; 3. Meet the indications for anesthesia; 4. Estimated operation time: no more than 2 hours; 5. Mentally normal and willing to cooperate with the research

Exclusion criteria

Exclusion criteria: 1.May present with suspected difficult airway or obesity; 2.History of alcohol dependence or drug dependence; 3.History of allergy to the anesthetic drugs used in this study; 4.Abnormal function of major organs such as the heart, liver, and kidneys; 5.History of recent upper respiratory tract infection; 6.Pregnant or lactating women;

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure;Heart rate;Oxygen saturation;

Secondary

MeasureTime frame
Surgical duration, time to loss of eyelash reflex, and time for the Bispectral Index (BIS) to drop below 60 during anesthesia induction are measured to evaluate the anesthetic efficacy.;The number of times propofol and remimazolam need to be supplemented during the surgery;Adverse reactions;During the recovery of anesthesia and SAS;

Countries

China

Contacts

Public ContactGuo Genhua

Ji 'an Central People's Hospital

824022178@qq.com+86 15079698090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026